Clinical Stage III Gastric Cancer AJCC v8 Not Yet Recruiting Phase 1 Trials for Capecitabine (DB01101)

IndicationStatusPhase
DBCOND0113386 (Clinical Stage III Gastric Cancer AJCC v8)Not Yet Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05296005Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric CancersTreatment